Autonomic Nervous System Dysfunction and Inflammation Contribute to the Increased Cardiovascular Mortality Risk Associated With Depression

Objective: To investigate prospectively whether autonomic nervous system (ANS) dysfunction and inflammation play a role in the increased cardiovascular disease (CVD)-related mortality risk associated with depression. Methods: Participants in the Cardiovascular Health Study (n = 907; mean age, 71.3 ± 4.6 years; 59.1% women) were evaluated for ANS indices derived from heart rate variability (HRV) analysis (frequency and time domain HRV, and nonlinear indices, including detrended fluctuation analysis (DFA1) and heart rate turbulence). Inflammation markers included C-reactive protein, interleukin-6, fibrinogen, and white blood cell count). Depressive symptoms were assessed, using the 10-item Centers for Epidemiological Studies Depression scale. Cox proportional hazards models were used to investigate the mortality risk associated with depression, ANS, and inflammation markers, adjusting for demographic and clinical covariates. Results: Depression was associated with ANS dysfunction (DFA1, p = .018), and increased inflammation markers (white blood cell count, p = .012, fibrinogen p = .043) adjusting for covariates. CVD-related mortality occurred in 121 participants during a median follow-up of 13.3 years. Depression was associated with an increased CVD mortality risk (hazard ratio, 1.88; 95% confidence interval, 1.23–2.86). Multivariable analyses showed that depression was an independent predictor of CVD mortality (hazard ratio, 1.72; 95% confidence interval, 1.05–2.83) when adjusting for independent HRV and inflammation predictors (DFA1, heart rate turbulence, interleukin-6), attenuating the depression-CVD mortality association by 12.7% (p < .001). Conclusion: Autonomic dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression, but a large portion of the predictive value of depression remains unexplained by these neuroimmunological measures. ANS = autonomic nervous system; LF = low frequency; CI = confidence interval; PNN50 = percent of successive RR interval differences >50 ms; CRP = C-reactive protein; CES-D = Centers for Epidemiological Studies Depression scale; PVC = premature ventricular complex; RMSSD = root mean square successive difference of RR intervals; CHS = Cardiovascular Health Study; CVD = cardiovascular disease; SD = standard deviation; DFA1 = detrended fluctuation analysis; SDNN = standard deviation of the NN intervals; HF = high frequency; HR = hazard ratio; HRT = heart rate turbulence; TO = turbulence onset; HRV = heart rate variability; TS = turbulence slope; VLF = very low frequency; IL-6 = interleukin-6; WBC = white blood cell count.

[1]  B. Pollock,et al.  The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients , 2009, Brain, Behavior, and Immunity.

[2]  F. Basile,et al.  Heart rate variability and myocardial infarction: systematic literature review and metanalysis. , 2009, European review for medical and pharmacological sciences.

[3]  E. Vittinghoff,et al.  Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. , 2008, JAMA.

[4]  Viola Vaccarino,et al.  Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. , 2008, American heart journal.

[5]  M. Marmot,et al.  Do Psychological Factors Affect Inflammation and Incident Coronary Heart Disease: The Whitehall II Study , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Louis T van Zyl,et al.  Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review , 2008, BioPsychoSocial medicine.

[7]  L. Manzoli,et al.  Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. , 2008, European heart journal.

[8]  P. Stein,et al.  Higher Levels of Inflammation Factors and Greater Insulin Resistance Are Independently Associated with Higher Heart Rate and Lower Heart Rate Variability in Normoglycemic Older Individuals: The Cardiovascular Health Study , 2008, Journal of The American Geriatrics Society.

[9]  S. Reis,et al.  Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. , 2007, Journal of the American College of Cardiology.

[10]  L. Fried,et al.  Depressive Symptoms, Inflammation, and Ischemic Stroke in Older Adults: A Prospective Analysis in the Cardiovascular Health Study , 2007, Journal of the American Geriatrics Society.

[11]  J. Bigger,et al.  Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. , 2007, Archives of general psychiatry.

[12]  A. Schene,et al.  Treatment of Post-Myocardial Infarction Depressive Disorder: A Randomized, Placebo-Controlled Trial With Mirtazapine , 2007, Psychosomatic medicine.

[13]  A. Steptoe,et al.  Association Between Physical Fitness, Parasympathetic Control, and Proinflammatory Responses to Mental Stress , 2007, Psychosomatic medicine.

[14]  R. Kronmal,et al.  The relationship of heart rate and heart rate variability to non‐diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[15]  A. Reiner,et al.  Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study , 2007, Journal of thrombosis and haemostasis : JTH.

[16]  A. Schene,et al.  Effects of antidepressant treatment following myocardial infarction , 2007, British Journal of Psychiatry.

[17]  F. Crea,et al.  Coronary heart disease Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients : effect of beta-blockade , 2007 .

[18]  R. Carney,et al.  Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. , 2007, Journal of psychosomatic research.

[19]  L. Kuller,et al.  Inflammation biomarkers and near-term death in older men. , 2007, American journal of epidemiology.

[20]  N. Frasure-smith,et al.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. , 2007, JAMA.

[21]  T. Seeman,et al.  Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. , 2007, Archives of internal medicine.

[22]  R. Carney,et al.  Heart Rate Turbulence, Depression, and Survival After Acute Myocardial Infarction , 2007, Psychosomatic medicine.

[23]  H. Kuper,et al.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. , 2006, European heart journal.

[24]  J. Thayer,et al.  Beyond Heart Rate Variability , 2006, Annals of the New York Academy of Sciences.

[25]  A. Rebuzzi,et al.  Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. , 2006, The American journal of cardiology.

[26]  A. Döring,et al.  C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. , 2005, European heart journal.

[27]  T. Seppänen,et al.  Physiological Background of the Loss of Fractal Heart Rate Dynamics , 2005, Circulation.

[28]  J. Polak,et al.  C-Reactive Protein and the 10-Year Incidence of Coronary Heart Disease in Older Men and Women: The Cardiovascular Health Study , 2005, Circulation.

[29]  X. Jouven,et al.  Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) , 2005, Circulation.

[30]  D. Berman,et al.  Social Network and Coronary Artery Calcification in Asymptomatic Individuals , 2005, Psychosomatic medicine.

[31]  J. Gottdiener,et al.  The role of immune system parameters in the relationship between depression and coronary artery disease. , 2005, Psychosomatic medicine.

[32]  Karina W Davidson,et al.  The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. , 2005, Journal of the American College of Cardiology.

[33]  Phyllis K Stein,et al.  Traditional and Nonlinear Heart Rate Variability Are Each Independently Associated with Mortality after Myocardial Infarction , 2005, Journal of cardiovascular electrophysiology.

[34]  A. Moss,et al.  Noninvasive risk stratification in postinfarction patients with severe left ventricular dysfunction and methodology of the MADIT II noninvasive electrocardiology substudy. , 2003, Journal of electrocardiology.

[35]  N. Schneiderman,et al.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.

[36]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[37]  S. Humphries,et al.  In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[38]  R. Califf,et al.  Sertraline treatment of major depression in patients with acute MI or unstable angina , 2002, European Neuropsychopharmacology.

[39]  M. Bourassa,et al.  Five-Year Risk of Cardiac Mortality in Relation to Initial Severity and One-Year Changes in Depression Symptoms After Myocardial Infarction , 2002, Circulation.

[40]  L. Fried,et al.  Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. , 2002, The American journal of cardiology.

[41]  Marek Malik,et al.  Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). , 2002, The American journal of cardiology.

[42]  H. Kraemer,et al.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.

[43]  A J Camm,et al.  Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials , 2001, Circulation.

[44]  J. Polak,et al.  Association between physical activity and markers of inflammation in a healthy elderly population. , 2001, American journal of epidemiology.

[45]  W. Kop,et al.  Association between depression and mortality in older adults: the Cardiovascular Health Study. , 2000, Archives of internal medicine.

[46]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[47]  A. Camm,et al.  Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction , 1999, The Lancet.

[48]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[49]  H. Nagaraja,et al.  Heart rate variability: origins, methods, and interpretive caveats. , 1997, Psychophysiology.

[50]  L. Fried,et al.  Correlates of performance-based measures of muscle function in the elderly: the Cardiovascular Health Study. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[51]  L. Fried,et al.  Exercise intensity and subclinical cardiovascular disease in the elderly. The Cardiovascular Health Study. , 1997, American journal of epidemiology.

[52]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.

[53]  C. Peng,et al.  Age-related alterations in the fractal scaling of cardiac interbeat interval dynamics. , 1996, The American journal of physiology.

[54]  L. Kuller,et al.  White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study. Correlations with baseline clinical and demographic characteristics. , 1996, American journal of epidemiology.

[55]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[56]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[57]  P. Savage,et al.  Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[58]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[59]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[60]  H. Stanley,et al.  Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. , 1995, Chaos.

[61]  J. Gardin,et al.  Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. , 1994, American journal of epidemiology.

[62]  D L Patrick,et al.  Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). , 1994, American journal of preventive medicine.

[63]  S. Greenland,et al.  Simulation study of confounder-selection strategies. , 1993, American journal of epidemiology.

[64]  S. Cohen,et al.  Depression and immunity: a meta-analytic review. , 1993, Psychological bulletin.

[65]  J. Fleiss,et al.  Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction , 1992, Circulation.

[66]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[67]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[68]  L. Radloff The CES-D Scale , 1977 .